Revolutionary eye injection saved my sight, says first-ever patient | BBC News

Key Concepts

• Hypotony: Abnormally low intraocular pressure, leading to eyeball collapse and potential blindness.
• HPMC (Hydroxypropyl Methylcellulose): A clear gel, traditionally used in other eye surgeries, now repurposed to reinflate collapsed eyeballs.
• Retinal Detachment/Scrunched Retina: A condition where the retina separates from the back of the eye, causing vision loss; HPMC aims to flatten the retina.
• Silicon Oil: A traditional filler used for eye surgeries, but it obstructs vision due to its opacity.
• Intraocular Injection: The method of delivering HPMC directly into the back of the eye.

Restoring Sight with HPMC Gel: A Novel Treatment for Hypotony

This report details a groundbreaking medical advancement – the successful use of hydroxypropyl methylcellulose (HPMC) gel to restore sight and prevent blindness in patients suffering from hypotony, a rare condition characterized by dangerously low intraocular pressure. The treatment, described as “life-changing” by patients, offers a significant improvement over existing methods.

The Challenge of Hypotony and Traditional Treatments

Hypotony leads to the collapse of the eyeball, resulting in vision loss. Nikki Guy, a patient featured in the report, experienced blindness in one eye and rapid deterioration in the other due to this condition. Traditionally, doctors attempted to reinflate the eye using silicon oil. However, silicon oil’s opacity significantly compromises vision quality, making it unsuitable for patients needing clear sight for daily activities like driving or childcare. As Dr. [Name not explicitly stated in transcript] explains, “The quality of vision you get with silicon oil is not great.” The analogy of inflating a deflated ball or bike tire was used to illustrate the basic principle, but highlighted the crucial need for a transparent filling material.

The “Eureka Moment”: Repurposing HPMC Gel

The innovative solution involved repurposing HPMC, a clear gel already used in other types of eye surgery. The key breakthrough was the decision to inject the gel behind the eye, a method previously unexplored in a rigorous manner. This approach, described as the “Eureka moment,” allows the gel to effectively reinflate the eyeball without obstructing vision. The gel functions similarly to an “iron to flatten off the retina,” restoring its proper shape.

Visualizing the Impact: Before and After Scans

The report showcases eye scans demonstrating the dramatic impact of the HPMC treatment. While the visual difference on the scans may appear subtle, the difference between a scrunched-up (detached) retina and a flattened retina is the difference between sight and blindness. The scans visually represent the restoration of retinal structure.

Clinical Results and Patient Outcomes

Initial trials involving eight patients have yielded remarkably positive results. Seven out of the eight patients treated with monthly HPMC gel injections experienced significant improvements in their vision. Nikki Guy, for example, has regained the ability to pursue her passion for photography and actively participate in her child’s life. She states, “I can do that again. I can see my child grow up at every birthday… If my vision stays like this for the rest of my life, it would be absolutely brilliant.” While acknowledging the possibility she may not regain her driving privileges, she expresses immense gratitude for the restored vision.

Future Implications and Standardization of Treatment

The medical community anticipates that HPMC gel injections will become the standard treatment for hypotony, potentially benefiting hundreds, if not thousands, of patients. The treatment’s success highlights the potential of repurposing existing, inexpensive substances to address previously intractable medical challenges. The report concludes with a hopeful outlook, suggesting a future where vision loss due to hypotony is significantly reduced.

Notable Quote

“It’s incredible. Like, it’s life-changing. It’s given me everything back. It’s somebody who by all rights should have lost her vision in both eyes and should have now really no vision at all based on the way we used to practice who is now living life normally.” – Doctor (unnamed) describing the impact of the treatment.